The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts

By Lutter G.   Attmann T.   Heilmann C.   von Samson P.   von Specht B.   Beyersdorf F.  

European Journal of Cardio-Thoracic Surgery, Vol. 22, Iss. 5, 2002-11 ,pp. : 753-761

Elsevier

Access to resources Recommend Favorite

Transmyocardial Laser Revascularization: Current Status

By Puc Matthew M.   Levin Steven   Tran Hoang S.   Marra Steve   Hewitt Charles W.   Rossi Anthony J. Del  

Journal of Investigative Surgery, Vol. 13, Iss. 1, 2000-01 ,pp. : 15-27

Informa Healthcare

Access to resources Recommend Favorite

A UK trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris

By Campbell H.E.   Tait S.   Buxton M.J.   Sharples L.D.   Caine N.   Schofield P.M.   Wallwork J.  

European Journal of Cardio-Thoracic Surgery, Vol. 20, Iss. 2, 2001-08 ,pp. : 312-318

Elsevier

Access to resources Recommend Favorite

Clinical data and histological features of transmyocardial revascularization with CO 2 -laser

By Gassler N.   Stubbe H.-M.  

European Journal of Cardio-Thoracic Surgery, Vol. 12, Iss. 1, 1997-07 ,pp. : 25-30

Elsevier

Access to resources Recommend Favorite

Transmyocardial laser - revascularization: experimental studies on prolonged acute regional ischemia

By Lutter G.   Yoshitake M.   Takahashi N.   Nitzsche E.   Martin J.   Sarai K.   Lutz C.   Friedhelm Beyersdorf  

European Journal of Cardio-Thoracic Surgery, Vol. 13, Iss. 6, 1998-06 ,pp. : 694-701

Elsevier

Access to resources Recommend Favorite